Genomics-driven personalised care presents an incredible opportunity to transform patient outcomes and create substantial efficiencies for the healthcare system.
Illumina and the University of Melbourne are partnering affordable, scaleable next-generation sequencing with the research expertise, infrastructure, systems and analysis needed to implement genomics into routine clinical care.
Based in the Melbourne Biomedical Precinct, our collaborative, cross-disciplinary approach translates evidence-based advancements into the clinic, supporting local training and jobs.​
The Illumina-University of Melbourne partnership will lift local genomics research and clinical trials to a global scale and quality, driving collaboration within the Precinct through the development of three core enabling platforms in clinical genomics, bioinformatics, and health economics.
-
The Advanced Genomics Collaboration
Global leader in genomics, Illumina has partnered with the University of Melbourne to create a biomedical and economic powerhouse for Australia by building a Genomics Hub inside our world-leading Melbourne Biomedical Precinct—The Advanced Genomics Collaboration (TAGC).
-
The need
Increasing genomics innovation and its translation and adoption into the healthcare system to improve patient outcomes.
-
Recruitment
Opportunities to join our core enabling research platforms and programs.
-
People
The researchers behind the core enabling platforms.
-
What is genomics?
Genomics is the study of genes and what they do.